Second paediatric strategy forum on medicine development for mature B cell malignancies in children

  • Email
  • Help

Details

TitleSecond paediatric strategy forum on medicine development for mature B cell malignancies in children
Date13/11/2017 - 14/11/2017
LocationEuropean Medicines Agency, London, UK
SummaryThis second multi-stakeholder paediatric strategy forum, jointly organised by ACCELERATE and the European Medicines Agency, will focus on mature B cell malignancies (lymphoma and leukaemia) in children. The goal of this meeting is to share information, in a pre-competitive setting, which will inform a paediatric drug development strategy and subsequent decisions and facilitate the developments of innovative medicines for the treatment of children with mature B cell malignancies. Participation is restricted and on invitation only. Interested parties, including patients and parent-representatives, academia, clinicians and industry, should express their interest. For clinicians and researchers, priority will be given to those who have expertise and experience in clinical trials for mature B cell malignancies in children or intend to design such studies in the future.

All documents

Name Language First published Last updated
Draft programme - Paediatric strategy forum for medicinal product development for mature B cell malignancies in children (English only) 2017-06-01 2017-06-29

Media Videos


Registration

  • Registration by invitation only
  • Registration open until 30 June 2017

Expression of interest

Related content

External links